Korkmaz, T. Et Al. 2011. Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC). JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15 .

Korkmaz, T., Seber, S., BAŞARAN, G., Yumuk, P. F., Dane, F., Okutur, K., ... Kanitez, M.(2011). Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC). JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.

Korkmaz, Taner Et Al. "Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011

Korkmaz, Taner Et Al. "Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011

Korkmaz, T. Et Al. (2011) . "Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.

@article{article, author={Taner Korkmaz Et Al. }, title={Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}